HLA-DQA2 and glioma: Furthermore, ROC analysis was performed to determine the diagnostic value of HLA-DQA2, HOXA3, and SAA2 in the survival of IDH1mt-glioma patients, and all showed remarkable diagnostic value (AUC = 0.832, 0.896, and 0.857) (Figures 10D–F).